Abbott Laboratories (ABT) Current Deferred Tax Assets (2009 - 2014)

Abbott Laboratories has disclosed Current Deferred Tax Assets across 6 years of filings, most recently posting $1.7 billion for Q4 2014.

• Current Deferred Tax Assets for Q4 2014 came in at $1.7 billion, down 32.56% year-over-year; the trailing twelve-month figure through Dec 2014 was $1.7 billion (down 32.56% YoY), and the FY2014 annual result was $1.7 billion, down 32.56% from the prior year.
• Current Deferred Tax Assets came in at $1.7 billion for Q4 2014 at Abbott Laboratories, down from $2.5 billion in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $3.1 billion in Q4 2010 to a low of $1.7 billion in Q4 2014.
• The 5-year median for Current Deferred Tax Assets is $2.7 billion (2011), against an average of $2.6 billion.
• Across the five-year window, Current Deferred Tax Assets surged 30.11% in 2010 and sank 32.56% in 2014, its largest moves.
• Abbott Laboratories' Current Deferred Tax Assets stood at $3.1 billion in 2010, then dropped by 12.19% to $2.7 billion in 2011, then climbed by 10.55% to $3.0 billion in 2012, then dropped by 15.34% to $2.5 billion in 2013, then tumbled by 32.56% to $1.7 billion in 2014.
• The last three Current Deferred Tax Assets figures came in at $1.7 billion (Q4 2014), $2.5 billion (Q4 2013), and $3.0 billion (Q4 2012), per Business Quant data.